SIRT1 is a deacetylase that modifies gene expression. Some researchers have found that SIRT1 is upregulated in malignant tumor tissues. Therefore, this study investigated the SIRT1 expression in gastric cardiac carcinoma and its correlation with clinicopathologic features and prognosis. Tissue microarray technique and immunohistochemical stains were used to detect the expression of SIRT1, p53, and Ki-67 in 176 gastric cardiac carcinoma tissues and 32 normal gastric cardiac region tissues. SIRT1 expression in gastric cardiac carcinoma was significantly higher than that in normal gastric cardiac tissues and was associated with lymphatic metastasis, TNM stage, survival rate and mean survival time. Expression of Ki-67 in the SIRT1 positive group was significantly higher than that in the negative group. In conclusion, high expression of SIRT1 in gastric cardiac carcinoma was correlated with lymphatic metastasis, TNM stage, proliferative status and prognosis. SIRT1 might be a biological parameter to evaluate malignant degree and prognosis of gastric cardiac carcinoma.
BlanderGGuarenteL.The Sir2 family of protein deacetylases. Annu Rev Biochem. 2004;73:417-435.
2.
ImaiSArmstrongCMKaeberleinMGuarenteL.Transcriptional silcencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 2000;403:795-800.
3.
Voelter-MahlnechtSMahlknechtU. Cloning. chromosomal characterization and mapping of the NAD-dependent histone deacetylases gene sirtuin 1. Int J Mol Med. 2006;17:59-67.
4.
VaqueroAScherMLeeDErdjument-BromageHTempstPReinbergD.Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell. 2004;16:93-105.
5.
LuoJNikolaevAYImaiS. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell. 2001;107:137-148.
6.
VaziriHDessainSKNg EatonE. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. 2001;107:149-159.
7.
Jung-HynesBNihalMZhongWAhmadN.Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition?J Biol Chem. 2009;284:3823-3832.
8.
ArakiTSasakiYMilbrandtJ.Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science. 2004;305:1010-1013.
9.
BordoneLMottaMCPicardF. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol. 2006;4:e31.
HidaYKuboYMuraoKAraseS.Strong expression of a longevity-related protein, SIRT1, in Bowen’s disease. Arch Dermatol Res. 2007;299:103-106.
12.
HuffmanDMGrizzleWEBammanMM. SIRT1 is significantly elevated in mouse and human prostate cancer. Cancer Res. 2007;67:6612-6618.
13.
PotetFFlejouJFGervazHParafF.Adenocarcinoma of the lower esophagus and the esophagogastric junction. Semin Diagn Pathol. 1991;8:126-136.
14.
MisumiAMurakamiAHaradaKBabaKAkagiM.Definition of carcinoma of the gastric cardia. Langenbecks Arch Chir. 1989;374:221-226.
15.
StemmermannGNFenoglio-PreiserC.Gastric carcinoma distal to the cardia: a review of the epidemiological pathology of the precursors to a preventable cancer. Pathology. 2002;34:494-503.
16.
KeeneySBauerTL. Epidemiology of adenocarcinoma of the esophagogastric junction. Surg Oncol Clin N Am. 2006;15:687-696.
17.
SakataHFujimotoK.Barrett’s esophagus and Helicobacter pylori [in Japanese]. Nippon Rinsho. 2005;63:1383-1386.
18.
InomataYKoikeTOharaS. Preservation of gastric acid secretion may be important for the development of gastroesophageal junction adenocarcinoma in Japanese people, irrespective of the H. pylori infection status. Am J Gastroenterol. 2006;101:926-933.
19.
SchumpelickVDreuwBOphoffKFassJ.Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux—surgical results in 122 patients [in German]. Leber Magen Darm. 1996;26:75-86.
20.
SaitoHFukumotoYOsakiT. Distinct recurrence pattern and outcome the adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach. World J Surg. 2006;30:1864-1869.
21.
JangKYHwangSHKwonKS. SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma. Am J Surg Pathol. 2008;32:1523-1531.
22.
ChaEJNohSJKwonKS. Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma. Clin Cancer Res. 2009;15:4453-4459.
23.
LevineAJ. p53, the cellular gatekeeper for growth and division. Cell. 1997;88:323-331.
24.
LozanoGElledgeSJ. p53 sends nucleotides to repair DNA. Nature. 2000;404:24-25.
25.
FordJJiangMMilnierJ.Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival. Cancer Res. 2005;65:10457-10463.
26.
OtaHTokunagaEChangK. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells. Oncogene. 2006;25:176-185.
27.
HeltwegBGatbontonTSchulerAD. Antitumor activity of a small-molecule inhibitor of thuman silent information regulator 2 enzymes. Cancer Res. 2006;66:4368-4377.
28.
SunYSunDLiF. Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells. Lung Cancer. 2007;58:21-29.
29.
NemotoSFergussonMMFinkelT.Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science. 2004;306:2105-2108.
30.
YamakuchiMFerlitoMLowensteinCJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A. 2008;105:13421-13426.
31.
RamiresM.An immunohistochemical study using double staining for the evaluation of the proliferative activity of diffuse type carcinomas. J Pathol. 1997;182:62-67.
32.
KojimaKOhhashiRFujitaY. A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells. Biochem Biophys Res Commun. 2008;373:423-428.
33.
HuangJGanQHanL. SIRT1 overexpression antagonizes cellular senescence with activated ERK/S6k1 signaling in human diploid fibroblasts. PLoS ONE. 2008;3(3):e1710.
34.
OtaHAkishitaMEtoMIijimaKKanekiMOuchiY.Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J Mol Cell Cardiol. 2007;43:571-579.
35.
KarpinichNOTafaniMRothmanRJRussoMAFarberJL. The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c. J Biol Chem. 2002;277:16547-16552.
36.
SomasundaramK.Tumor suppressor p53: regulation and function. Front Biosci. 2001;5:D424-D437.
37.
BlanderGBhimavarapuAMammoneT. SIRT1 promotes differentiation of normal human keratinocytes. J Invest Dermatol. 2009;129:41-49.
38.
FiresteinRBlanderGMichanS. The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS ONE. 2008;3(4):e2020.
39.
NaralaSRAllsoppRCWellsTB. SIRT1 acts as a nutrient-sensitive growth suppressor and its loss is associated with increased AMPK and telomerase activity. Mol Biol Cell. 2008;19:1210-1219.
40.
FuMLiuMSauveAA. Hormonal control of androgen receptor function through SIRT1. Mol Cell Biol. 2006;26:8122-8135.
41.
KuboACorleyDA. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer. 2002;95:2096-2102.
42.
CaiLZhengZLZhangZF. Risk factors for the gastric cardia cancer: a case-control study in Fujian Province. World J Gastroenterol. 2003;9:214-218.
43.
MuellerJDSteinHJOyangT. Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction. Cancer. 2000;89:1874-1882.
44.
HuangQZhangLH. The histopathologic spectrum of carcinomas involving the gastroesophageal junction in the Chinese. Intl J Surg Pathol. 2007;15:1-15.
45.
DaiYNgoDFormanLWQinDCJacobJFallerDV. Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor. Mol Endocrinol. 2007;21:1807-1821.
46.
PruittKZinnRLOhmJE. Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hepermethylation. PLoS Genet. 2006;2(3):e40.
